|
|
|
|
Office Locations:
|
50 East 91st St., Suite 213
Indianapolis, IN 46240
Phone: 317-975-1901
Fax: 317-252-0255
| | |
|
|
|
|
|
Communications & Networking
Defense & Homeland Security
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
Software & Internet
|
|
|
|
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies. The three funds managed by Elevate Ventures provide startup capital to Indiana companies in the life sciences, information technology and advanced manufacturing industries. The Indiana Community Development Fund is dedicated to supporting community-interested assets focused on early-stage businesses in Indiana with high growth potential. This program is initially available in the Northern Indiana regions, but will be expanded to Southern Indiana as this region becomes part of Elevate Ventures' statewide network. The ICD Fund's maximum investment size is $50,000 per company. The Indiana Angel Network Fund is a source of seed capital dedicated to discovering and nurturing emerging, high-potential, innovation-based companies within the State of Indiana. The IAN Fund's maximum investment size is currently $125,000 per company. The goal of the 21st Century Fund is to support the resolution of next-stage capital formation issues by co-investing with institutional investors in order to further build innovative, high-impact, high-growth companies. The 21 Fund's maximum investment size is $2 million per company. 4,005 companies impacted; 507 Indiana startups funded.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
| Barbara Uggen-Davis | |
CPA, CMA | |
Chief Financial Officer | |
| Erica Schweyer | |
MBA | |
COO | |
| Phil Lodato | |
| |
Chief Compliance Officer and General Counsel | |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
04/03/2024
|
Neurava
|
IN
|
$2,000,000
|
Series A
|
02/29/2024
|
PawCo Foods
|
CA
|
$2,000,000
|
Seed
|
11/16/2023
|
On Target Laboratories
|
IN
|
$30,000,000
|
Series C
|
10/23/2023
|
Laxis
|
IN
|
$1,500,000
|
Seed
|
09/29/2023
|
Overfuel
|
IN
|
$500,000
|
Pre-Seed
|
08/08/2023
|
Stamus Networks
|
IN
|
$6,000,000
|
Series A
|
05/17/2023
|
Qualifi
|
IN
|
$4,500,000
|
|
|
|
|
|
|
|
|
